These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1272953)

  • 1. [Basic definitions from the field of biopharmacy and pharmacokinetics].
    Krówczyński L; Danek A
    Pol Tyg Lek; 1976 Apr; 31(14):601-2. PubMed ID: 1272953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various thoughts on biopharmacy and pharmacokinetics of today].
    Zathurecký L
    Pharmazie; 1971 Nov; 26(11):650-2. PubMed ID: 5154312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic concepts of biopharmacy and pharmacokinetics (author's transl)].
    Krówczyński L; Danek A
    Przegl Lek; 1976; 33(3):418-9. PubMed ID: 1273337
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biopharmacy and pharmacokinetics].
    Janků I
    Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in developing a standard terminology in biopharmaceutics and pharmacokinetics.
    Zathurecký L
    Drug Intell Clin Pharm; 1977 May; 11(5):281-96. PubMed ID: 10318382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics--questions of terminology and problems].
    von Hattingberg HM
    Arzneimittelforschung; 1975 Jul; 25(7a):1126-33. PubMed ID: 1242341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics in relation to age.
    Gladtke E
    Boll Chim Farm; 1973 May; 112(5):333-41. PubMed ID: 4761111
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic non-equivalence.
    Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 12. Manual of symbols, equations & definitions in pharmacokinetics.
    J Clin Pharmacol; 1982 Jul; 22(7):1S-23S. PubMed ID: 7107975
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioequivalence studies: a new EMA guideline.
    Houin G
    Arzneimittelforschung; 2010; 60(4):169-70. PubMed ID: 20486464
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetic methods for the evaluation of intestinal absorption].
    Kübler W
    Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029
    [No Abstract]   [Full Text] [Related]  

  • 17. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biopharmacy].
    Modrzejewski F
    Pharmazie; 1971 Nov; 26(11):661. PubMed ID: 5154318
    [No Abstract]   [Full Text] [Related]  

  • 19. [Understanding bioprecursors].
    Huy P; Grenier JP
    Inf Dent; 1983 Apr; 65(16):1381-6. PubMed ID: 6574976
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the patient a fast or a slow acetylator?
    Drug Ther Bull; 1974 Mar; 12(6):21-2. PubMed ID: 4457304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.